。
To the scientific world, Moderna’s MRNA -1.25%decrease; down pointing triangle cancer vaccine’s results proved that a highly personalized, immune-targeting medication can work. To investors, it didn’t work well enough.
Moderna疫苗研究的细节显示，当该疫苗与免疫疗法联用时，与单独使用免疫疗法相比，可将黑色素瘤复发风险降低42%。
Details from Moderna’s vaccine study showed that, when added to immunotherapy, it reduced the risk of melanoma returning by 42% when compared with immunotherapy alone.